These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27163850)

  • 61. Efficacy of human serum butyrylcholinesterase against sarin vapor.
    Saxena A; Sun W; Dabisch PA; Hulet SW; Hastings NB; Jakubowski EM; Mioduszewski RJ; Doctor BP
    Chem Biol Interact; 2008 Sep; 175(1-3):267-72. PubMed ID: 18597747
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning.
    Rochu D; Chabrière E; Masson P
    Toxicology; 2007 Apr; 233(1-3):47-59. PubMed ID: 17007987
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Enzymes hydrolyzing organophosphates as potential catalytic scavengers against organophosphate poisoning.
    Masson P; Josse D; Lockridge O; Viguié N; Taupin C; Buhler C
    J Physiol Paris; 1998; 92(5-6):357-62. PubMed ID: 9789837
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Progress in acetylcholinesterase reactivators and in the treatment of organophosphorus intoxication: a patent review (2006-2016).
    Gorecki L; Korabecny J; Musilek K; Nepovimova E; Malinak D; Kucera T; Dolezal R; Jun D; Soukup O; Kuca K
    Expert Opin Ther Pat; 2017 Sep; 27(9):971-985. PubMed ID: 28569609
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Engineering of catalytic bioscavengers of organophosphorus compounds].
    Masson P; Nachon F; Rochu D
    Bull Acad Natl Med; 2007 Jan; 191(1):95-111; discussion 112. PubMed ID: 17645110
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of organophosphorus hydrolysing enzymes on obidoxime-induced reactivation of organophosphate-inhibited human acetylcholinesterase.
    Herkenhoff S; Szinicz L; Rastogi VK; Cheng TC; DeFrank JJ; Worek F
    Arch Toxicol; 2004 Jun; 78(6):338-43. PubMed ID: 14985944
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The role of PON1 and CYP2D6 genes in susceptibility to organophosphorus chronic intoxication in Egyptian patients.
    Tawfik Khattab AM; Zayed AA; Ahmed AI; AbdelAal AG; Mekdad AA
    Neurotoxicology; 2016 Mar; 53():102-107. PubMed ID: 26723569
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evolved stereoselective hydrolases for broad-spectrum G-type nerve agent detoxification.
    Goldsmith M; Ashani Y; Simo Y; Ben-David M; Leader H; Silman I; Sussman JL; Tawfik DS
    Chem Biol; 2012 Apr; 19(4):456-66. PubMed ID: 22520752
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of human and guinea pig acetylcholinesterase sequences and rates of oxime-assisted reactivation.
    Cadieux CL; Broomfield CA; Kirkpatrick MG; Kazanski ME; Lenz DE; Cerasoli DM
    Chem Biol Interact; 2010 Sep; 187(1-3):229-33. PubMed ID: 20433814
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Assessing the stoichiometric efficacy of mammalian expressed paraoxonase-1 variant I-F11 to afford protection against G-type nerve agents.
    Mata DG; Sabnekar P; Watson CA; Rezk PE; Chilukuri N
    Chem Biol Interact; 2016 Nov; 259(Pt B):233-241. PubMed ID: 27083144
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Degradation of nerve agents by an organophosphate-degrading agent (OpdA).
    Dawson RM; Pantelidis S; Rose HR; Kotsonis SE
    J Hazard Mater; 2008 Sep; 157(2-3):308-14. PubMed ID: 18258361
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Next generation OP-bioscavengers: a circulatory long-lived 4-PEG hypolysine mutant of F338A-HuAChE with optimal pharmacokinetics and pseudo-catalytic characteristics.
    Kronman C; Cohen O; Mazor O; Ordentlich A; Raveh L; Velan B; Shafferman A
    Chem Biol Interact; 2010 Sep; 187(1-3):253-8. PubMed ID: 20005217
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Perspectives in the treatments of poisonings by organophosphorus insecticides and warfare nerve agents].
    Sogorb-Sánchez MA; Vilanova-Gisbert E; Carrera-González V
    Rev Neurol; 2004 Oct 16-31; 39(8):739-47. PubMed ID: 15514903
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A 10-minute point-of-care assay for detection of blood protein adducts resulting from low level exposure to organophosphate nerve agents.
    VanDine R; Babu UM; Condon P; Mendez A; Sambursky R
    Chem Biol Interact; 2013 Mar; 203(1):108-12. PubMed ID: 23200942
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oximes in organophosphate poisoning: 60 years of hope and despair.
    Worek F; Thiermann H; Wille T
    Chem Biol Interact; 2016 Nov; 259(Pt B):93-98. PubMed ID: 27125761
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In vitro kinetics of nerve agent degradation by fresh frozen plasma (FFP).
    Wille T; Thiermann H; Worek F
    Arch Toxicol; 2014 Feb; 88(2):301-7. PubMed ID: 24057572
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase.
    Mazor O; Cohen O; Kronman C; Raveh L; Stein D; Ordentlich A; Shafferman A
    Mol Pharmacol; 2008 Sep; 74(3):755-63. PubMed ID: 18523134
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Polyethylene glycosylation prolongs the stability of recombinant human paraoxonase-1.
    Tiegang L; Nana W; Heng D; Min Z
    Toxicol Lett; 2012 May; 210(3):366-71. PubMed ID: 22414384
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of polyethylene glycol-conjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds.
    Cohen O; Kronman C; Raveh L; Mazor O; Ordentlich A; Shafferman A
    Mol Pharmacol; 2006 Sep; 70(3):1121-31. PubMed ID: 16801396
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gene-environmental interactions and organophosphate toxicity.
    Povey AC
    Toxicology; 2010 Dec; 278(3):294-304. PubMed ID: 20156521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.